Implantable device cuts obstructive sleep apnea symptoms

Since the 1980s, continuous positive airway pressure (CPAP) -- in which positive pressure is pushed through the nasal airways to help users breathe while sleeping - has been by far the most widely used treatment for obstructive sleep apnea (OSA). With more than 18 million people experiencing OSA, a number expected to rise, new results from a case study of a new device implanted in the chest called hypoglossal nerve stimulation (HGNS) offers promise for patients with moderate to severe OSA who cannot tolerate CPAP.

Originally published at https://www.sciencedaily.com/releases/2016/06/160610173610.htm